Dottikon Exclusive Synthesis AG, Switzerland
Dottikon Exclusive Synthesis – a product/project-related co-operation partner for Active Pharmaceutical Ingredients and Intermediates.
The Company:
Dottikon Exclusive Synthesis specialises in producing organic intermediates and bulk active ingredients for the pharmaceutical industry. Custom synthesis is carried out using the company's expertise in nitration, catalytic hydrogenation, oxidation and other processes, such as bromination, cyanidation, Grignard synthesis.
Specific Strengths:
- Production of Indoles, Indazoles, Benzimidazoles, Benzofuranes, etc.
- Environmental Reliability by State-of-the-Art Recycling and Waste Handling (incl. high-temperature incineration facilities).
The company is certified to ISO 9001 and carries out custom synthesis under non-disclosure agreement, complying with cGMP-regulations when producing bulk pharmaceuticals. The whole plant is FDA-approved (last audit June 1999), including multi-purpose manufacturing facilities from pilot plant up to 10 m³ reactors.
